• Medicskin Holdings held its annual general meeting on Aug. 6, 2026, passing all resolutions put to shareholders.
• Shareholders adopted the audited consolidated financial statements and the directors’ and auditor’s reports for the year ended March 31, 2026.
• Director changes were endorsed, without assuming any subsequent appointments or changes have been implemented.
• Grant Thornton Hong Kong was reappointed as auditor, subject to the board setting its remuneration.
• Shareholders granted mandates to issue up to 20% additional shares, buy back up to 10% of shares, and extend the issuance mandate by shares repurchased.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicskin Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260806-12275100), on August 06, 2026, and is solely responsible for the information contained therein.